+73.3%
CVS vs CLSK
-61.9%
+135.3%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -1.5% | +0.8% | -0.7% |
| 7D | -1.9% | +17.2% | -19.1% | -2.0% |
| 30D | -0.3% | +14.6% | -14.9% | -0.4% |
| 3M | -1.1% | -16.8% | +15.7% | -1.1% |
| 6M | +23.7% | +38.2% | -14.5% | +23.4% |
| YTD | +23.0% | +31.2% | -8.2% | +22.7% |
| 1Y | +37.2% | +37.3% | -0.2% | +36.7% |
| 3Y | +62.4% | +201.8% | -139.4% | +61.2% |
| 5Y | +31.8% | -1.6% | +33.4% | +30.7% |
| All | +73.3% | -61.9% | +135.3% | +77.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling